Floatz logo

Docetaxel

Adenocarcinoma of the Lung

Sichuan Baili Pharmaceutical Co., Ltd.Small moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

67 Active assets in the Adenocarcinoma of the Lung cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Anusha Kalbasi
Phase 2BBB
Carboplatin
Guangdong Association of Clinical Trials
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Guangdong Association of Clinical Trials
Phase 3BB
ETOPOSIDE
Guangdong Association of Clinical Trials
Phase 3BB

View all 50 →

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
pancreatic adenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →